Abstract:Recent in vitro studies have investigated the effects of hemoadsorption therapy on endothelial function in sepsis showing a reduction in markers of endothelial dysfunction, but, to this day, there are no clinical studies proving whether this approach could actually positively influence the disturbed vascular barrier function in septic conditions. We retrospectively analyzed data on administered fluid volumes and catecholamines in 124 septic shock patients. We collected catecholamine and volume requirements and calculated the volume balance within different time periods to obtain an assumption on the stability of the vascular barrier. Regarding the entire study cohort, our findings revealed a significant reduction in fluid balance at 72 h (T72) compared to both baseline (T0) and the 24 h mark (T24). Fluid balances from T72–T0 were significantly lower in hospital survivors compared with non-survivors. Patients who received a second catecholamine had a significantly lower in-hospital mortality. Our findings suggest that the applied treatment regimen including hemoadsorption therapy is associated with a reduced positive fluid balance paralleled by reductions in vasopressor needs, suggesting a potential positive effect on endothelial integrity. These results, derived from a large cohort of patients, provide valuable insights on the multiple effects of hemoadsorption treatment in septic shock patients.

What problem does this paper attempt to address?

### Problems the paper attempts to solve This paper aims to explore the impact of CytoSorb hemoadsorption therapy on the fluid balance of patients with septic shock. Specifically, the researchers hope to evaluate whether this treatment can reduce capillary leakage and vascular permeability, thereby improving endothelial function and clinical outcomes, by retrospectively analyzing the fluid balance and catecholamine requirements of 124 septic shock patients who received CytoSorb hemoadsorption therapy. ### Background and research objectives 1. **Background**: - Sepsis is a life - threatening condition that occurs when an infection spreads beyond the local tissue and triggers a series of dysregulated physiological responses, leading to organ dysfunction. - Despite various efforts, the mortality rate of sepsis remains high, with approximately 11 million deaths worldwide each year. - Endothelial cells and their outermost glycocalyx play a sensor role in infection and inflammation, serving as the first immune defense line against invading pathogens and being responsible for maintaining normal vascular function and homeostasis. - The early stage of sepsis is characterized by the activation of the innate immune system, which triggers the release of inflammatory mediators. These mediators activate multiple downstream cascades, which may ultimately lead to a pro - inflammatory and pro - coagulant state, further exacerbating tissue hypoxia, hypoperfusion, microvascular thrombosis, increased vascular permeability, capillary leakage and impaired endothelial function, and finally leading to organ dysfunction. 2. **Research objectives**: - Evaluate the fluid balance and catecholamine requirements in patients with septic shock treated with CytoSorb hemoadsorption therapy. - Explore whether this treatment can reduce capillary leakage and vascular permeability, thereby improving endothelial function and clinical outcomes. - By analyzing the changes in fluid balance, assess the potential impact of the treatment on endothelial stability. ### Main findings 1. **Changes in fluid balance**: - In the entire study cohort, the fluid balance at 72 hours (T72) was significantly lower compared to the baseline (T0) and 24 hours (T24). - The reduction in fluid balance from T72 to T0 in survivors was significantly greater than that in non - survivors. 2. **Changes in catecholamine requirements**: - The requirement for catecholamines also decreased within 72 hours, which was consistent with the improvement in fluid balance. - The in - hospital mortality rate of patients using the second catecholamine was significantly reduced. 3. **Correlation analysis**: - There was a positive correlation between the changes in fluid balance and catecholamine requirements, that is, the improvement in fluid balance was not at the cost of additional use of catecholamines. - There was a weak negative correlation between fluid balance and the amount of blood treated, that is, the more blood treated, the more obvious the reduction in fluid balance. ### Conclusion The research results indicate that CytoSorb hemoadsorption therapy may have a positive impact on the fluid balance and clinical outcomes of patients with septic shock by reducing capillary leakage and vascular permeability and improving endothelial function. These findings provide a new perspective for the application of hemoadsorption therapy in sepsis management.

Impact of CytoSorb Hemoadsorption Therapy on Fluid Balance in Patients with Septic Shock

Effects of Hemoadsorption with a Novel Adsorbent on Sepsis: In vivo and in vitro Study

Cytokine hemoadsorption with CytoSorb® in patients with sepsis: a systematic review and meta-analysis

Effect of Fluid Resuscitation on Adhesion Molecule and Hemodynamics in Patients with Severe Sepsis

Effect of Hemadsorption Therapy in Critically Ill Patients with COVID-19 (CYTOCOV-19): A Prospective Randomized Controlled Pilot Trial

Changes in Cytokines, Haemodynamics and Microcirculation in Patients with Sepsis/Septic Shock Undergoing Continuous Renal Replacement Therapy and Blood Purification with CytoSorb

Septic Shock Secondary to β-hemolytic Streptococcus-induced Necrotizing Fasciitis treated with a Novel Cytokine Adsorption Therapy

Simultaneous removal of endotoxins, inflammatory mediators and uremic toxins in ICU patients with septic shock: a retrospective cohort study

Benefit of Hemoadsorption Therapy in Patients Suffering Sepsis-Associated Acute Kidney Injury: A Case Series

Continuous Hemoadsorption with a Cytokine Adsorber during Sepsis – a Review of the Literature

Clinical efficacy of oXiris-continuous hemofiltration adsorption in septic shock patients: A retrospective analysis

Fluid boluses and infusions in the early phase of resuscitation from septic shock and sepsis-induced hypotension: a retrospective report and outcome analysis from a tertiary hospital

Assessment of outcomes in patients with heart failure and end-stage kidney disease following fluid resuscitation for sepsis and septic shock

Effects of high volume haemodiafiltration on inflammatory response profile and microcirculation in patients with septic shock

Sublingual Microcirculatory Evaluation of Extracorporeal Hemoadsorption with CytoSorb® in Abdominal Sepsis: A Case Report

From New Hemodynamics to Blood Purification Therapies

Fluids and Early Vasopressors in the Management of Septic Shock: Do We Have the Right Answers Yet?

Dynamics of organ dysfunction and inflammation markers in patients with septic shock during multimodal hemocorrection: a multicenter, randomized, controlled study

CytoSorb Rescue for COVID-19 Patients With Vasoplegic Shock and Multiple Organ Failure: A Prospective, Open-Label, Randomized Controlled Pilot Study

Clinical efficacy of hemoperfusion with a cytokine adsorbent in norepinephrine-resistant septic shock: protocol for the CLEANSE randomized clinical trial

Effect of oXiris-CVVH on the Clinical Outcomes of Patients with Septic Shock: An Inverse Probability of Treatment-Weighted Analysis